ADIL MOHYUDIN
Allopathic & Osteopathic Physicians|Internal Medicine JACKSON, MS NPI 1851913172
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine MS Incyte Corporation All categories
General Payments — all program years on this page
$1,235.18
- Category: General Payments
- Program years: PY2021–2024
- Record count: 42
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $740.92 across 32 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $650.93 | 31 |
| Education | $89.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $114.74 | 2 |
| Acerta Pharma LLC | $76.33 | 2 |
| ABBVIE INC. | $64.83 | 3 |
| Celgene Corporation | $63.29 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $62.24 | 4 |
| Rigel Pharmaceuticals, Inc. | $47.04 | 2 |
| Alexion Pharmaceuticals, Inc. | $40.88 | 1 |
| Merck Sharp & Dohme Corporation | $33.83 | 2 |
| Janssen Biotech, Inc. | $32.87 | 2 |
| GENZYME CORPORATION | $32.65 | 2 |
| PharmaEssentia USA Corporation | $25.17 | 1 |
| Stemline Therapeutics Inc. | $24.25 | 1 |
| PFIZER INC. | $21.59 | 1 |
| TAIHO ONCOLOGY, INC. | $19.95 | 1 |
| SOBI, INC | $18.92 | 1 |
| ARRAY BIOPHARMA INC | $17.13 | 1 |
| GlaxoSmithKline, LLC. | $15.54 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.33 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.34 | 1 |
By program year
Records — PY2024 (32)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.